3//SEC Filing
Hallett David 3
Accession 0002006495-26-000008
CIK 0001601830other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 7:18 PM ET
Size
20.8 KB
Accession
0002006495-26-000008
Insider Transaction Report
Form 3
Holdings
- 287,928
Class A Common Stock
- 277,759
Class A Common Stock
- 28,454
Class A Common Stock
Stock Option (Right to Buy)
Exercise: $7.25Exp: 2035-02-02→ Class A Common Stock (70,037 underlying)Stock Option (Right to Buy)
Exercise: $6.09Exp: 2034-12-18→ Class A Common Stock (740,686 underlying)Stock Option (Right to Buy)
Exercise: $0.01Exp: 2032-03-31→ Class A Common Stock (56,531 underlying)Stock Option (Right to Buy)
Exercise: $0.01Exp: 2032-03-31→ Class A Common Stock (75,375 underlying)Stock Option (Right to Buy)
Exercise: $0.01From: 2026-04-04Exp: 2033-04-02→ Class A Common Stock (80,510 underlying)Stock Option (Right to Buy)
Exercise: $0.01Exp: 2033-04-02→ Class A Common Stock (80,510 underlying)Stock Option (Right to Buy)
Exercise: $0.01From: 2025-03-15Exp: 2034-04-14→ Class A Common Stock (9,241 underlying)Stock Option (Right to Buy)
Exercise: $0.01From: 2027-04-17Exp: 2034-04-14→ Class A Common Stock (150,888 underlying)Stock Option (Right to Buy)
Exercise: $0.01Exp: 2034-04-14→ Class A Common Stock (150,888 underlying)
Footnotes (10)
- [F1]Represents RSUs with each RSU representing the right to receive one share of Class A common stock. The RSUs vest in equal quarterly installments beginning February 15, 2025 through November 15, 2028, subject to the Reporting Person continuing to be a service provider through the applicable vesting date.
- [F10]The option was vested as to 18,862 shares upon the Issuer's assumption of the option at the time of the acquisition of Exscientia plc on November 20, 2024, and the remaining 132,026 shares vest in equal amounts quarterly, starting on December 15, 2024 through March 15, 2028, subject to Reporting Person continuing as a service provider though each vesting date.
- [F2]Represents RSUs with each RSU representing the right to receive one share of Class A common stock. The RSUs vest in equal quarterly installments beginning May 15, 2025 through February 15, 2029, subject to the Reporting Person continuing to be a service provider through the applicable vesting date.
- [F3]The option vests as to one forty-eighth (1/48th) of the original 70,037 shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F4]The option vests as to one forty-eighth (1/48th) of the original 740,686 shares subject to the option on January 2, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F5]The option was vested as to 35,333 shares upon the Issuer's assumption of the option at the time of the acquisition of Exscientia plc on November 20, 2024, and the remaining 21,198 shares vest in equal amounts quarterly, starting on December 15, 2024 through March 15, 2026, subject to Reporting Person continuing as a service provider though each vesting date.
- [F6]This option is vested and fully exercisable.
- [F7]This option will become vested and exercisable on the Date Exercisable subject to the Reporting Person continuing as a service provider through such date.
- [F8]The option was vested as to 30190 shares upon the Issuer's assumption of the option at the time of the acquisition of Exscientia plc on November 20, 2024, and the remaining 50,320 shares vest in equal amounts quarterly, starting on December 15, 2024 through March 15, 2027, subject to Reporting Person continuing as a service provider though each vesting date.
- [F9]This option is vested and fully exercisable
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0002006495
Filing Metadata
- Form type
- 3
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 7:18 PM ET
- Size
- 20.8 KB